TNBI Tanke Biosciences Corp.

Fundamentals / CIK 0001452011 / USD

Tanke Biosciences Corp. reported $22.96M in revenue and a net loss of $1.64M for the trailing twelve months ended September 30, 2013 (down 39.0% year over year), with a 32.3% gross margin and a -0.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TNBI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2009 to 2012), reported in USD.

$28.48M$14.24M$0-$5.36MFY 2009 Net Income: $2.58M2009FY 2010 Revenue: $20.10MFY 2010 Net Income: $2.74M2010FY 2011 Revenue: $23.83MFY 2011 Net Income: -$3.14M2011FY 2012 Revenue: $28.56MFY 2012 Net Income: -$210K2012

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $28.56M $23.83M $20.10M --
Cost of Revenue $18.62M $15.06M $12.70M --
Gross Profit $9.94M $8.77M $7.40M --
Research & Development $291K $246K -- --
Selling, General & Admin $5.25M $6.95M $2.72M --
Operating Income $4.53M $1.74M $4.37M --
EBITDA $5.17M $2.14M $4.51M --
Interest Income $296K $96K $4.8K --
Interest Expense $1.45M $1.36M $100K --
Income Before Tax $603K -$2.45M $4.28M --
Income Tax Expense $832K $681K $582K --
Net Income -$210K -$3.14M $2.74M $2.58M
Basic EPS -$0.02 -$0.24 $0.34 --
Diluted EPS -$0.02 -$0.24 $0.34 --
Basic Shares Outstanding 13.3M 13.1M 10.8M --
Diluted Shares Outstanding 13.3M 13.1M 10.8M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Revenue $6.04M $5.58M $4.66M $6.68M $9.91M $7.43M $4.54M $6.65M
Cost of Revenue $4.35M $3.75M $2.99M $4.45M $6.52M $4.69M $2.95M $4.33M
Gross Profit $1.69M $1.82M $1.67M $2.23M $3.39M $2.74M $1.59M $2.33M
Selling, General & Admin $2.15M $1.62M $1.64M $1.75M $1.19M $1.23M $1.09M $1.39M
Operating Income -$530K $150K -$40K $363K $2.18M $1.50M $489K $1.02M
EBITDA -$287K $356K $140K $595K $2.34M $1.62M $612K $1.29M
Interest Income $147K $19K $7.3K $103K $24K $148K $21K $67K
Interest Expense -$47K $39K $215K $387K $316K $369K $373K -$136K
Income Before Tax -$340K $169K -$647K -$620K $1.19M $586K -$554K $2.16M
Income Tax Expense -$27K $54K $32K $179K $223K $314K $117K $176K
Net Income -$302K $118K -$676K -$780K $969K $272K -$671K $1.99M
Basic EPS -$0.02 $0.01 -$0.05 -- $0.07 $0.02 -$0.05 --
Diluted EPS -$0.02 $0.01 -$0.05 -- $0.07 $0.02 -$0.05 --
Basic Shares Outstanding 13.3M 13.3M 13.3M -- 13.3M 13.3M 13.3M --
Diluted Shares Outstanding 13.3M 13.3M 13.3M -- 13.3M 13.3M 13.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $6.17M $7.70M $2.22M
Cash & Short-Term Investments $6.17M $7.70M $2.22M
Accounts Receivable, Net $1.99M $1.92M $1.77M
Inventory $1.41M $1.19M $1.35M
Other Current Assets $133K $915K $165K
Total Current Assets $22.37M $18.91M $7.67M
Property, Plant & Equipment, Net $4.81M $4.77M $1.55M
Intangible Assets $1.24M $838K $287K
Other Non-Current Assets $135K $328K $0
Total Non-Current Assets $6.48M $5.97M $5.59M
Total Assets $28.85M $24.89M $13.27M
Accounts Payable $647K $785K $605K
Short-Term Debt $1.27M $785K $906K
Total Current Liabilities $12.10M $3.55M $2.41M
Long-Term Debt $793K $628K $453K
Total Non-Current Liabilities $831K $5.49M $526K
Total Liabilities $12.93M $9.03M $2.93M
Total Debt (incl. Leases) $2.06M $1.41M $1.36M
Common Stock $13K $13K $11K
Retained Earnings $2.49M $2.70M $5.83M
Accumulated Other Comp. Income $659K $551K $530K
Total Stockholders' Equity $15.75M $15.85M $8.16M
Total Equity $15.92M $15.85M $10.33M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-03-31 2011-12-31 2011-09-30
Cash & Cash Equivalents $5.05M $4.72M $5.59M $6.17M $11.04M $7.64M $7.70M $10.22M
Cash & Short-Term Investments $5.05M $4.72M $5.59M $6.17M $11.04M $7.64M $7.70M $10.22M
Accounts Receivable, Net $2.76M $2.38M $1.85M $1.99M $2.28M $1.72M $1.92M $5.06M
Inventory $1.65M $2.08M $1.40M $1.41M $1.64M $1.36M $1.19M $1.08M
Other Current Assets $30K $8.2K $18K $133K $340K $746K $915K $1.42M
Total Current Assets $19.70M $21.92M $21.74M $22.37M $22.20M $18.37M $18.91M $21.24M
Property, Plant & Equipment, Net $6.34M $5.26M $5.16M $4.81M $4.92M $4.88M $4.77M $4.58M
Intangible Assets $1.15M $1.19M $1.20M $1.24M $1.27M $845K $838K $301K
Other Non-Current Assets -- -- -- $135K $121K $359K $328K --
Total Non-Current Assets $9.11M $7.55M $6.92M $6.48M $6.64M $6.08M $5.97M $5.18M
Total Assets $28.81M $29.47M $28.66M $28.85M $28.84M $24.45M $24.89M $26.41M
Accounts Payable $641K $843K $659K $647K $582K $514K $785K $551K
Short-Term Debt $1.14M $1.29M $797K $1.27M $1.34M $1.11M $785K $708K
Total Current Liabilities $12.24M $12.70M $11.79M $12.10M $11.16M $8.82M $3.55M $5.18M
Long-Term Debt $733K $809K $1.43M $793K $948K $0 $628K $944K
Total Non-Current Liabilities $863K $891K $1.48M $831K $1.15M $335K $5.49M $6.87M
Total Liabilities $13.10M $13.59M $13.28M $12.93M $12.31M $9.16M $9.03M $12.05M
Total Debt (incl. Leases) $1.87M $2.10M $2.23M $2.06M $2.29M $1.11M $1.41M $1.65M
Common Stock $13K $13K $13K $13K $13K $13K $13K $13K
Retained Earnings $1.63M $1.93M $1.81M $2.49M $3.27M $2.03M $2.70M $1.08M
Accumulated Other Comp. Income $1.32M $1.17M $791K $659K $660K $664K $551K $1.04M
Total Stockholders' Equity $15.56M $15.71M $15.21M $15.75M $16.53M $15.30M $15.85M --
Total Equity $15.71M $15.88M $15.38M $15.92M $16.53M $15.30M $15.85M $14.36M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$229K -$3.14M $3.69M $2.58M
Depreciation & Amortization $636K $400K $136K --
Stock-Based Compensation -- $2.49M $0 --
Change in Receivables -$172K -$170K -$240K --
Change in Inventory -$227K $173K -$334K --
Change in Payables -$138K $153K $555K --
Operating Cash Flow -$1.18M $3.65M $4.38M --
Capital Expenditure -$856K -$701K -$76K --
Free Cash Flow -$2.04M $2.95M $4.31M --
Investing Cash Flow -$1.53M -$3.67M -$2.82M --
Financing Cash Flow $1.12M $5.82M -$1.22M --
Net Change in Cash -$1.53M $5.48M $404K --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Net Income -$313K $116K -$679K -$799K $969K $272K -$671K $1.99M
Depreciation & Amortization $243K $206K $180K $232K $160K $121K $124K $274K
Stock-Based Compensation -- -- -- -- -- -- $0 --
Change in Receivables -$214K -$493K $139K $186K -$460K -$94K $197K $2.98M
Change in Inventory $349K -$602K $17K $223K -$381K $103K -$172K -$156K
Change in Payables -$202K $184K $13K $65K -$102 $68K -$271K $232K
Operating Cash Flow $1.61M -$135K -$101K -$5.01M $1.55M $1.77M $509K $731K
Capital Expenditure -$1.07M -$613K -$746K -$56K -$412K -$195K -$194K -$224K
Free Cash Flow $538K -$748K -$847K -$5.07M $1.14M $1.57M $315K $507K
Investing Cash Flow -$1.08M -$645K -$746K $114K -$394K -$866K -$380K -$2.11M
Financing Cash Flow -$241K -$159K $230K $76K -$45K $1.40M -$305K -$466K
Net Change in Cash $329K -$861K -$583K -$4.87M $1.01M $2.40M -$64K -$2.52M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 34.8% 36.8% 36.8% --
Operating Margin 15.9% 7.3% 21.8% --
Net Profit Margin -0.7% -13.2% 13.6% --
Return on Equity (ROE) -1.3% -19.8% 33.5% --
Return on Assets (ROA) -0.7% -12.6% 20.6% --
Current Ratio 1.85x 5.33x 3.19x --
Quick Ratio 1.73x 5.00x 2.63x --
Debt to Equity 0.13x 0.09x 0.17x --
Revenue Growth (YoY) +19.8% +18.6% -- --
Gross Profit Growth (YoY) +13.4% +18.5% -- --
Operating Income Growth (YoY) +160.6% -60.2% -- --
Net Income Growth (YoY) -- -214.5% +6.0% --
EPS Growth (YoY) -- -170.6% -- --
Operating Cash Flow Growth (YoY) -132.4% -16.7% -- --
Free Cash Flow Growth (YoY) -169.1% -31.5% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Gross Margin 32.3% 33.9% 34.9% 34.8% 35.2% 35.8% -- --
Operating Margin -0.2% 9.9% 14.0% 15.9% 18.2% 16.9% -- --
Net Profit Margin -7.1% -1.4% -0.8% -0.7% 9.0% 0.6% -- --
Return on Equity (ROE) -10.5% -2.4% -1.4% -1.3% 15.5% -- -- --
Return on Assets (ROA) -5.7% -1.3% -0.8% -0.7% 8.9% -- -- --
Current Ratio 1.61x 1.73x 1.84x 1.85x 1.99x -- 2.08x 5.33x
Quick Ratio 1.48x 1.56x 1.72x 1.73x 1.84x -- 1.93x 5.00x
Debt to Equity 0.12x 0.13x 0.15x 0.13x 0.14x -- 0.07x 0.09x
Revenue Growth (YoY) -39.0% -25.0% +2.6% +0.4% +58.6% -- -23.6% --
Gross Profit Growth (YoY) -50.0% -33.5% +4.9% -4.1% +50.9% -- -34.6% --
Operating Income Growth (YoY) -124.3% -90.0% -108.2% -64.4% +81.3% -- -- --
Net Income Growth (YoY) -131.2% -56.6% -- -139.2% -- -- -- --
EPS Growth (YoY) -128.6% -50.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) +3.8% -107.6% -119.9% -785.6% -- -- -53.9% --
Free Cash Flow Growth (YoY) -52.8% -147.6% -368.9% -1100.2% -- -- -64.7% --
Source: SEC EDGAR CompanyFacts (CIK 0001452011) · from December 31, 2009 Data through September 30, 2013 · synced Nov 21, 2026, 05:14 UTC · Open in terminal